Abstract: Apparatus and methods are disclosed for processing messages from agents of a network environment including the use of collectors. Collectors can use configurable pipelines to improve processing of messages received from the agents. In one example of the disclosed technology, a number of networked agents are configured to gather data describing operational aspects of an agent's computing host. A collector is configured to receive reports from the agent and send the gathered data to one or more destination agent data consumers designated by augmentation information in the reports. In some examples, the collector transforms data using one or more stage selector rules.

Abstract: A material delivery interface includes a fixed assembly that is coupled to a primary structural attachment. The fixed assembly includes a fluid inlet and a wired input, wherein the fixed assembly defines a central axis. A rotational assembly is rotationally coupled to the fixed assembly and that rotates about the central axis with respect to the fixed assembly. The rotational assembly includes an inner portion having a fluid outlet in fluid communication with the fluid inlet and an outer portion having a wired output, wherein a conduit extends from the wired input to the wired output.

Abstract: A material delivery interface includes a fixed assembly that is coupled to a primary structural attachment. The fixed assembly includes a fluid inlet and a wired input, wherein the fixed assembly defines a central axis. A rotational assembly is rotationally coupled to the fixed assembly and that rotates about the central axis with respect to the fixed assembly. The rotational assembly includes an inner portion having a fluid outlet in fluid communication with the fluid inlet and an outer portion having a wired output, wherein a conduit extends from the wired input to the wired output.

Abstract: A material delivery interface includes a fixed assembly that is coupled to a primary structural attachment. The fixed assembly includes a fluid inlet and a wired input, wherein the fixed assembly defines a central axis. A rotational assembly is rotationally coupled to the fixed assembly and that rotates about the central axis with respect to the fixed assembly. The rotational assembly includes an inner portion having a fluid outlet in fluid communication with the fluid inlet and an outer portion having a wired output, wherein a conduit extends from the wired input to the wired output.

Abstract: The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a suspension for a sterilizing-effective time. The methods and compositions according to the invention are useful as therapeutic tools to prevent, reverse, and/or reduce the symptoms of allergic and/or inflammatory conditions in a mammalian patient. The invention also provides methods and compositions, which may be manipulated and fine-tuned to fit the condition(s) to be treated while producing fewer side effects.

Abstract: A material delivery interface includes a fixed assembly that is coupled to a primary structural attachment. The fixed assembly includes a fluid inlet and a wired input, wherein the fixed assembly defines a central axis. A rotational assembly is rotationally coupled to the fixed assembly and that rotates about the central axis with respect to the fixed assembly. The rotational assembly includes an inner portion having a fluid outlet in fluid communication with the fluid inlet and an outer portion having a wired output, wherein a conduit extends from the wired input to the wired output.

Abstract: A robotic material handling apparatus comprises a packing head using vacuum to lift bottles, and a robot arm including two four-bar linkages. The four-bar linkages include a tubular structural member forming a rigid link with an internal passageway extending along the robot arm. A vacuum source is connected by hoses to the internal passageways and to the packing head as a way in integrating the vacuum lines into the robot arm. The packing head has bottle-lifting stations using vacuum to lift bottles, each including a seal shaped to sealingly engage a shoulder on the bottle. A vacuum source is connected to the seal for suctionally gripping the bottle using the shoulder to lift the bottle, regardless of whether a bottle cap is present or is missing.

Abstract: A robotic material handling apparatus comprises a packing head using vacuum to lift bottles, and a robot arm including two four-bar linkages. The four-bar linkages include a tubular structural member forming a rigid link with an internal passageway extending along the robot arm. A vacuum source is connected by hoses to the internal passageways and to the packing head as a way in integrating the vacuum lines into the robot arm. The packing head has bottle-lifting stations using vacuum to lift bottles, each including a seal shaped to sealingly engage a shoulder on the bottle. A vacuum source is connected to the seal for suctionally gripping the bottle using the shoulder to lift the bottle, regardless of whether a bottle cap is present or is missing.

Abstract: The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a suspension for a sterilizing-effective time. The methods and compositions according to the invention are useful as therapeutic tools to prevent, reverse, and/or reduce the symptoms of allergic and/or inflammatory conditions in a mammalian patient. The invention also provides methods and compositions, which may be manipulated and fine-tuned to fit the condition(s) to be treated while producing fewer side effects.

Abstract: The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a suspension for a sterilizing-effective time. The methods and compositions according to the invention are useful as therapeutic tools to prevent, reverse, and/or reduce the symptoms of allergic and/or inflammatory conditions in a mammalian patient. The invention also provides methods and compositions, which may be manipulated and fine-tuned to fit the condition(s) to be treated while producing fewer side effects.

Abstract: The present invention provides a method for preparing a sterile suspension of a glucocorticosteroid. The glucocorticosteroids used in the invention are preferably antiinflammatory glucocorticosteroids. By making the last stage of product preparation be the sterilization process, the potential for contamination during manufacture and heat degradation of products is greatly reduced.

Abstract: The present invention provides a method for preparing a sterile suspension of a glucocorticosteroid. The glucocorticosteroids used in the invention are preferably antiinflammatory glucocorticosteroids. By making the last stage of product preparation be the sterilization process, the potential for contamination during manufacture and heat degradation of products is greatly reduced.

Abstract: The present invention provides a method for preparing a sterile suspension of a glucocorticosteroid. The glucocorticosteroids used in the invention are preferably antiinflammatory glucocorticosteroids. By making the last stage of product preparation be the sterilization process, the potential for contamination during manufacture and heat degradation of products is greatly reduced.

Abstract: The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a suspension for a sterilizing-effective time. The methods and compositions according to the invention are useful as therapeutic tools to prevent, reverse, and/or reduce the symptoms of allergic and/or inflammatory conditions in a mammalian patient. The invention also provides methods and compositions, which may be manipulated and fine-tuned to fit the condition(s) to be treated while producing fewer side effects.